Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Patients With Diabetic Peripheral Neuropathic Pain: a Randomized, Placebo-controlled Study of South Asian Male Patients

NCT04238208 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT04238208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04238208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Patients With Diabetic Peripheral Neuropathic Pain: a Randomized, Placebo-controlled Study of South Asian Male Patients
Lead sponsor
Corporacion Parc Tauli
Phase
Phase 4
Overall status
Completed
Start date
January 10, 2019
Completion date
January 2, 2020
Enrollment
290 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic complications neurological, diabetic nerve problems, diabetic neuropathy